LeMaitre Vascular (LMAT) Meets Q4 Earnings Estimates

Group 1: Earnings Performance - LeMaitre Vascular reported quarterly earnings of $0.49 per share, matching the Zacks Consensus Estimate and showing an increase from$ 0.38 per share a year ago [1] - The company exceeded earnings expectations of $0.44 per share from a quarter ago, delivering a surprise of 11.36% [1] - Over the last four quarters, LeMaitre has surpassed consensus EPS estimates three times [1] Group 2: Revenue Performance - LeMaitre posted revenues of$ 55.72 million for the quarter ended December 2024, which was 0.76% below the Zacks Consensus Estimate [2] - This revenue figure represents an increase from $48.88 million in the same quarter last year [2] - The company has also topped consensus revenue estimates three times over the last four quarters [2] Group 3: Stock Performance and Outlook - LeMaitre shares have increased approximately 11.8% since the beginning of the year, outperforming the S&P 500's gain of 1.3% [3] - The future performance of the stock will depend on management's commentary during the earnings call and the earnings outlook [4][6] - The current consensus EPS estimate for the upcoming quarter is$ 0.51 on revenues of $58.68 million, and for the current fiscal year, it is$ 2.17 on revenues of $242.49 million [7] Group 4: Industry Context - The Medical - Products industry, to which LeMaitre belongs, is currently ranked in the bottom 49% of over 250 Zacks industries [8] - Research indicates that the top 50% of Zacks-ranked industries outperform the bottom 50% by more than a factor of 2 to 1 [8]